T. Rowe Price Associates’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $481K | Buy |
|
|||||
|
2017
Q4 | $410K | Hold |
|
|||||
|
2017
Q3 | $499K | Sell |
|
|||||
|
2017
Q2 | $530K | Sell |
|
|||||
|
2017
Q1 | $468K | Buy |
|
|||||
|
2016
Q4 | $322K | Buy |
|
|||||
|
2016
Q3 | $565K | Buy |
|
|||||
|
2016
Q2 | $578K | Hold |
|
|||||
|
2016
Q1 | $642K | Buy |
|
|||||
|
2015
Q4 | $837K | Buy |
|
|||||
|
2015
Q3 | $630K | Hold |
|
|||||
|
2015
Q2 | $822K | Buy |
|
|||||
|
2015
Q1 | $750K | Sell |
|
|||||
|
2014
Q4 | $580K | Hold |
|
|||||
|
2014
Q3 | $434K | Hold |
|
|||||
|
2014
Q2 | $549K | Hold |
|
|||||
|
2014
Q1 | $483K | Buy |
|
|||||
|
2013
Q4 | $365K | Sell |
|
|||||
|
2013
Q3 | $361K | Hold |
|
|||||
|
2013
Q2 | $351K | Buy |
|